These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4973138)

  • 41. Rh antibody quantitation in amniotic fluid.
    Fraser ID; Tovey GH
    Br J Haematol; 1971 Sep; 21(3):358-9. PubMed ID: 4998793
    [No Abstract]   [Full Text] [Related]  

  • 42. Management of pregnancy complicated by Rh-immunization. Review with respect to own investigations and results.
    Bartsch FK
    Pathologica; 1972; 64(929):139-48. PubMed ID: 4210413
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship between maternal anti-D levels, fetal phenotype and haemolytic disease of the newborn.
    Morley G
    Vox Sang; 1978; 35(5):324-31. PubMed ID: 99877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of iso-immunization to Rh factor treated successfully with trans-umbilical intrauterine blood transfusion. Clinical and morphological study].
    Keymer E; Gomez M; Iglesias J; Kohan M; Nuñez A; Saavedra G; Vernal M; Ossandon M
    Rev Chil Obstet Ginecol; 1968; 33(6):382-6. PubMed ID: 4985626
    [No Abstract]   [Full Text] [Related]  

  • 45. [alpha-Fetoprotein in the amniotic fluid of isoimmunized pregnant women].
    Matveeva NK; Volkova LS; Smirnova LK
    Akush Ginekol (Mosk); 1980 Apr; (4):21-3. PubMed ID: 6155793
    [No Abstract]   [Full Text] [Related]  

  • 46. [Maternal-fetal blood group incompatibility in the light of recent statistical and immunohematological data].
    Ragonese P; Rizzo F; Ricevuto C; D'Angelo S; Liotti B
    Minerva Ginecol; 1976 Jan; 28(1):26-30. PubMed ID: 815851
    [No Abstract]   [Full Text] [Related]  

  • 47. Amniocentesis of the sensitized Rh-negative patient. A combined study in 2 community hospitals.
    Price JJ; Gunster GD; Bracken SJ
    Obstet Gynecol; 1968 Jun; 37(6):829-35. PubMed ID: 4995813
    [No Abstract]   [Full Text] [Related]  

  • 48. Prediction of the severity of rhesus haemolytic disease by means of antibody titrations performed on the Autoanalyzer.
    Tovey LA; Haggas WK
    Br J Haematol; 1971 Jan; 20(1):25-33. PubMed ID: 4992955
    [No Abstract]   [Full Text] [Related]  

  • 49. IgG subclasses of anti-Rh antibodies in pregnant women.
    Frankowska K; Górska B
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):1095-100. PubMed ID: 107909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and treatment of erythroblastosis in the fetus.
    Liley AW
    Adv Pediatr; 1968; 15():29-63. PubMed ID: 4966222
    [No Abstract]   [Full Text] [Related]  

  • 51. ERYTHROPOIETIN LEVELS IN THE AMNIOTIC FLUID, PARTICULARLY IN RH-IMMUNIZED PREGNANCIES.
    FINNE PH
    Acta Paediatr (Stockh); 1964 May; 53():269-81. PubMed ID: 14158481
    [No Abstract]   [Full Text] [Related]  

  • 52. [Direct positive Coombs test for Rh isoimmunization].
    Cabrera A; Barbolla L; Arrieta R; Fernandez MN
    Sangre (Barc); 1973; 18(4):528-33. PubMed ID: 4209569
    [No Abstract]   [Full Text] [Related]  

  • 53. Non-"D" rhesus and irregular antibodies--an approach to management.
    Dornan KJ
    Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
    [No Abstract]   [Full Text] [Related]  

  • 54. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
    Bowell P; Wainscoat JS; Peto TE; Gunson HH
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):327-9. PubMed ID: 6284295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rh system genotyping in amniotic fluid].
    Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Martino W; Racca A
    Medicina (B Aires); 2001; 61(1):76-8. PubMed ID: 11265629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AMNIOCENTESIS FOR PRENATAL DIAGNOSIS OF ERYTHROBLASTOSIS FETALIS.
    QUEENAN JT; ADAMS DW
    Obstet Gynecol; 1965 Mar; 25():302-7. PubMed ID: 14268009
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effectiveness of prophylactic administration of anti-Rh (D) immunoglobulin, based on immunofluorescent and cytochemical methods of fetal hemoglobin determination].
    Gajewska E
    Pediatr Pol; 1973 Jun; 48(6):721-6. PubMed ID: 4198490
    [No Abstract]   [Full Text] [Related]  

  • 60. [Methods for the study of fetal erythroblastosis due to Rh and their standardization: amniotic fluid].
    Bellati U; Morici A
    Pathologica; 1972; 64(937):359-62. PubMed ID: 4210484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.